- Home
- AMS vs CRIS Comparison
AMS vs CRIS Comparison
Compare AMS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMS | CRIS |
|---|---|---|
| Founded | 1980 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 14.0M |
| IPO Year | 1995 | 2000 |
Fundamental Metrics
Financial Performance| Metric | AMS | CRIS |
|---|---|---|
| Price | $1.82 | $0.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 3.8K | ★ 231.2K |
| Earning Date | 05-14-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 230.00 | 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,714,000.00 | $9,898,000.00 |
| Revenue This Year | $3.81 | $32.24 |
| Revenue Next Year | N/A | $66.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.81 | ★ 31.50 |
| 52 Week Low | $1.79 | $0.52 |
| 52 Week High | $3.11 | $3.13 |
Technical Indicators
Market Signals| Indicator | AMS | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 23.83 | 26.17 |
| Support Level | N/A | N/A |
| Resistance Level | $2.19 | $1.04 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 7.35 | 14.42 |
Price Performance
Historical ComparisonAbout AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.